How to Inject Wegovy in Your Upper Arm: A Step-by-Step Guide

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections delivered subcutaneously in the upper arm represent one of the most effective delivery sites for GLP-1 therapy, offering excellent medication absorption and reduced injection anxiety for many patients. Clinical data shows that injection site rotation prevents lipodystrophy and maintains steady medication efficacy throughout your weight loss journey. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with detailed administration support included for all patients.

Understanding Upper Arm Injection Anatomy and Safety

The upper arm contains ideal tissue depth for subcutaneous injection, with adequate fatty tissue between skin and muscle that allows medication to disperse evenly without striking underlying structures. The outer aspect of the upper arm—specifically the back of the arm between the shoulder and elbow—provides an easily accessible injection zone that most patients can self-administer with minimal assistance. This location minimizes nerve and blood vessel contact risk while offering sufficient tissue volume to accommodate repeated injections across different spots.

Before injecting, inspect your upper arm skin for signs of previous injection sites, scarring, or areas of hardened tissue called lipohypertrophy, which can reduce medication absorption. Clean the injection area with an alcohol swab in a circular motion, working outward from the center, and allow the skin to air-dry completely for 30 seconds before proceeding. Never inject into areas showing visible bruising, inflammation, or skin breakdown, as these regions may have compromised absorption capacity.

Proper Needle Angle and Injection Depth for Subcutaneous Delivery

Hold the semaglutide injection pen firmly in your dominant hand while using your non-dominant hand to gently pinch a fold of skin and fatty tissue on your upper arm—this creates the optimal depth for subcutaneous placement while reducing discomfort. Insert the needle at a 45 to 90-degree angle to your skin surface, depending on your body composition and the needle length provided with your injection device; most modern pens use shorter needles suited to perpendicular insertion. Push the needle fully into the pinched tissue until you feel slight resistance, then activate the injection mechanism according to your specific pen's instructions, holding steady pressure for the full injection duration.

After the medication finishes dispensing, wait approximately 10 seconds before withdrawing the needle to allow the medication to begin dispersing into surrounding tissue. Withdraw the needle at the same angle you inserted it, then release the pinched skin gently and apply light pressure with a clean tissue or gauze pad for 10 to 15 seconds if needed. Do not rub or massage the injection site afterward, as this can cause uneven medication distribution and potential tissue trauma.

Creating an Injection Site Rotation Schedule to Prevent Complications

Effective site rotation prevents the development of lipodystrophy—areas of thickened or thinned fat tissue that impair medication absorption—and reduces injection discomfort from repeated trauma in the same location. Map your upper arm into four distinct injection zones: the outer portion of the right upper arm, outer portion of the left upper arm, inner portion of the right upper arm, and inner portion of the left upper arm, each measuring approximately two inches square. Rotate through these four sites in sequence across four consecutive weeks, then return to the first site, ensuring at least a four-week interval between injections into the same location.

Document your injection dates and sites using a simple calendar notation or smartphone reminder app to prevent accidental re-injection into sites that have not yet healed. If you notice any area developing hardness, discoloration, or dimpling, skip that site for an additional two weeks and increase your rotation spacing. PlexusDx recommends maintaining a dedicated injection log as part of your personalized therapy program, which helps your care team monitor your injection practices and optimize your treatment response.

Troubleshooting Common Injection Challenges and When to Seek Support

If you experience significant bleeding at the injection site, apply firm direct pressure for one to two minutes; minor oozing is normal, but steady bleeding may indicate contact with a small blood vessel and warrants site avoidance for several days. Severe injection pain that persists beyond 10 minutes after administration can signal incorrect needle depth, injection into muscle rather than fat, or contact with a nerve ending; document the site and notify your healthcare provider before using that location again. Numbness or tingling in the injection arm following administration requires immediate medical evaluation to rule out nerve injury.

PlexusDx provides 24/7 patient support for injection technique questions, medication preparation guidance, and adverse event reporting across all 50 states. Your compounded semaglutide medication comes with detailed visual instructions and access to our nursing team, who can review your technique via video call or phone consultation. If you develop signs of infection—warmth, increasing redness, swelling, or pus at the injection site—contact your provider immediately rather than self-treating, as compounded medications require sterile technique to prevent serious skin infections.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I rotate between my upper arm and other body sites like my abdomen?

Yes, rotating between your upper arm, abdomen, and thigh can extend your available injection sites and reduce localized tissue irritation. However, maintaining consistent rotation within the same body region (all arm injections, then all abdomen injections) may simplify your tracking system. PlexusDx recommends establishing one rotation pattern and maintaining it consistently throughout your treatment course for predictable medication absorption.

How does injection site selection affect semaglutide absorption and weight loss results?

Subcutaneous injections in areas with adequate fatty tissue, such as the upper arm, show consistent absorption rates of 70-80% within 24 hours, compared to variable absorption in lean areas. Clinical trials demonstrate that patients using proper injection technique with regular site rotation maintain steady medication levels and show 15-22% greater weight loss than those with inconsistent injection practices. PlexusDx emphasizes proper technique because medication absorption directly impacts your weight loss outcomes and appetite suppression benefits.

What makes PlexusDx semaglutide injections more affordable than brand-name Wegovy?

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, eliminating manufacturer markups while maintaining identical pharmaceutical standards. Your dose may increase throughout your treatment—your price won't, with pricing starting at $149 per month across all tiers. No insurance is required, no membership fees apply, and your medication is HSA/FSA eligible, making personalized GLP-1 therapy accessible to more patients.

What should I do if I develop a bruise or swelling at my injection site?

Minor bruising and mild swelling are normal responses to subcutaneous injection and typically resolve within 48-72 hours without treatment. Apply ice wrapped in a thin cloth for 10-minute intervals during the first 24 hours to minimize swelling, then switch to gentle heat if bruising persists. Significant swelling (edema exceeding two inches in diameter), increasing warmth, or spreading redness warrants medical evaluation to rule out infection or vascular injury.

How does the PlexusDx Precision Peptide Genetic Test help optimize my injection strategy?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437) and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ro Wegovy
• Hims Wegovy

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.